ABSTRACT
Recently, professional and healthcare-related entities have launched frameworks designed to assess the value of cancer innovations in multistakeholder decision processes. Among the most visible entities that propose and implement value frameworks in oncology are the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the Memorial Sloan Kettering Cancer Center (MSKCC) and the National Comprehensive Cancer Network (NCCN). However, these value frameworks have been criticized for conceptual inconsistencies, inability to include a greater variety of value criteria, and inadequate explanation of the uncertainty approach used in the modeling process. On the other hand, Multi-Criteria Decision Analysis (MCDA) is a set of methods and processes that allow the multiple criteria involved in a decision to be explicitly addressed. This approach allows the identification of relevant decision criteria, gathering of evidence based on scientific literature, attribution of weights to the criteria and scores to the evidence raised, and aggregation of the weighted scores to constitute a global metric of value. The purpose of this article is to review the main features of these value frameworks in oncology and the importance of perspective for framework readiness to support healthcare decision-making based on MCDA methodology.
Subject(s)
Humans , Decision Support Systems, Clinical/standards , Clinical Decision-Making/methods , Medical Oncology/standards , Reference Standards , Cost-Benefit Analysis , Decision Support Systems, Clinical/economics , Delivery of Health Care/economics , Delivery of Health Care/standards , Medical Oncology/economicsSubject(s)
Humans , Health Care Costs , Health Care Economics and Organizations , Health Expenditures , Neoplasms , Medical Oncology/economics , Delivery of Health Care/statistics & numerical data , Social Security , Argentina , Cost of Illness , Health Expenditures , Neoplasms , Delivery of Health Care/economics , Delivery of Health Care/methods , Social SecurityABSTRACT
Projeto que examina os procedimentos ambulatoriais de alto custo nas áreas de Nefrologia e Oncologia. Apresenta o perfil de produçäo das duas áreas, seguido por análise dos seus custos. Estabelece um cardápio para orientar a supervisäo das unidades ambulatoriais de Nefrologia e Oncologia, acompanhado por um "critério de boa prática" que possa conduzir processos avaliativos futuros. Tendo Minas Gerais como estudo de caso, delineia uma proposta de estudo avaliativo para as áreas de nefrologia e oncologia